The role of sLZIP in transcriptional regulation of c-Jun and involvement in migration and invasion of cervical cancer cells

Cellular Physiology and Biochemistry

Volumn 33, Issue 1, 2014, Pages 151-164

  Park, Eunsoo ^a   Kang, Hyereen ^a   Kim, Jeonghan ^a   Ko, Jesang ^a  

^a Korea University   (South Korea)

Author keywords

c Jun; Cervical cancer; Invasion; Migration; MMP 9; sLZIP

Indexed keywords

CRE RECOMBINASE; GELATINASE B; MESSENGER RNA; PROTEIN C JUN; SMALL INTERFERING RNA; SMALL LEUCINE ZIPPER PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; CREB3 PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PROTEIN BINDING; BETA GALACTOSIDASE; LEUCINE ZIPPER PROTEIN;

ARTICLE; BINDING SITE; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CELL STRAIN LNCAP; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TUMOR INVASION; UPREGULATION; UTERINE CERVIX CANCER; CELL MOTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR; CELL INVASION; CELL PROLIFERATION; DOWN REGULATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 84893186189     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000356658     Document Type: Article

References (38)

1. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T: Regulation of matrix metalloproteinases: An overview. Mol Cell Biochem 2003;253:269-285.
2. Johansson N, Ahonen M, Kahari VM: Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 2000;57:5-15.
3. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 2003;92:827-839.
4. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-174.
5. Rao JS, Yamamoto M, Mohaman S, Gokaslan ZL, Fuller GN, Stetler-Stevenson WG, Rao VH, Liotta LA, Nicolson GL, Sawaya RE: Expression and localization of 92 kda type iv collagenase/gelatinase b (mmp-9] in human gliomas. Clin Exp Metastasis 1996;14:12-18.
6. Chang C, Werb Z: The many faces of metalloproteases: Cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 2001;ll:S37-43.
7. Sehgal G, Hua J, Bernhard EJ, Sehgal I, Thompson TC, Muschel RJ: Requirement for matrix metalloproteinase-9 (gelatinase b) expression in metastasis by murine prostate carcinoma. Am J Pathol 1998;152:591-596.
8. Hua J, Muschel RJ: Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res 1996;56:5279-5284.
9. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-744.
10. Suzuki T, Hashimoto Y, Okuno H, Sato H, Nishina H, Iba H: High-level expression of human c-jun gene causes cellular transformation of chicken embryo fibroblasts. Jpn J Cancer Res 1991;82:58-64.
11. Vogt PK, Bos TJ: Jun: Oncogene and transcription factor. Adv Cancer Res 1990;55:1-35.
12. Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, Moon YS, Davis GE, Brooks PC: Proteolytic exposure of a cryptic site within collagen type iv is required for angiogenesis and tumor growth in vivo. J Cell Biol 2001;154:1069-1079.
13. Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P, Wagner EF: Control of cell cycle progression by c-jun is p53 dependent. Genes Dev 1999;13:607-619.
14. Johnson R, Spiegelman B, Hanahan D, Wisdom R: Cellular transformation and malignancy induced by ras require c-jun. Mol Cell Biol 1996;16:4504-4511.
15. Chen SY, Cai C, Fisher CJ, Zheng Z, Omwancha J, Hsieh CL, Shemshedini L: C-jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation. Oncogene 2006;25:7212-7223.
16. Zhang G, Luo X, Sumithran E, Pua VS, Barnetson RS, Halliday GM, Khachigian LM: Squamous cell carcinoma growth in mice and in culture is regulated by c-jun and its control of matrix metalloproteinase-2 and-9 expression. Oncogene 2006;25:7260-7266.
17. Kanzler S, Meyer E, Lohse AW, Schirmacher P, Henninger J, Galle PR, Blessing M: Hepatocellular expression of a dominant-negative mutant tgf-beta type ii receptor accelerates chemically induced hepatocarcinogenesis. Oncogene 2001;20:5015-5024.
18. Knight B, Yeoh GC, Husk KL, Ly T, Abraham LJ, Yu C, Rhim JA, Fausto N: Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 2000;192:1809-1818.
19. Sharma P, Kumar S, Kundu GC: Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin a in cervical cancer cells. Mol Cancer 2010;9:178.
20. Loesch M, Zhi HY, Hou SW, Qi XM, Li RS, Basir Z, Iftner T, Cuenda A, Chen G: P38gamma mapk cooperates with c-jun in trans-activating matrix metalloproteinase 9. J Biol Chem 2010;285:15149-15158.
21. Lu R, YangP, O'Hare P, Misra V: Luman, a new member of the creb/atf family, binds to herpes simplex virus vpl6-associated host cellular factor. Mol Cell Biol 1997;17:5117-5126.
22. Luciano RL, Wilson AC: N-terminal transcriptional activation domain of lzip comprises two lxxll motifs and the host cell factor-1 binding motif. Proc Natl Acad Sci USA 2000;97:10757-10762.
23. Raggo C, Rapin N, Stirling J, Gobeil P, Smith-Windsor E, O'Hare P, Misra V: Luman, the cellular counterpart of herpes simplex virus vpl6, is processed by regulated intramembrane proteolysis. Mol Cell Biol 2002;22:5639-5649.
24. Kang H, Kim YS, Ko J: A novel isoform of human lzip negatively regulates the transactivation of the glucocorticoid receptor. Mol Endocrinol 2009;23:1746-1757.
25. Jang SY, Jang SW, Ko J: Regulation of adp-ribosylation factor 4 expression by small leucine zipper protein and involvement in breast cancer cell migration. Cancer Lett 2012;314:185-197.
26. Kang H, Jang SW, Ko J: Human leucine zipper protein slzip induces migration and invasion of cervical cancer cells via expression of matrix metalloproteinase-9. J Biol Chem 2011;286:42072-42081.
27. Crowe DL, Tsang KJ, Shemirani B: Jun n-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression. Neoplasia 2001;3:27-32.
28. Hong IK, Jin YJ, Byun HJ, Jeoung DI, Kim YM, Lee H: Homophilic interactions of tetraspanin cdl51 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-jun activation signaling pathways. J Biol Chem 2006;281:24279-24292.
29. Roomi MW, Monterrey JC, Kalinovsky T, Rath M, Niedzwiecki A: Patterns of mmp-2 and mmp-9 expression inhuman cancer cell lines. Oncol Rep 2009;21:1323-1333.
30. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980;284:67-68.
31. Sato T, Sakai T, Noguchi Y, Takita M, Hirakawa S, Ito A: Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol Oncol 2004;92:47-56.
32. Stetler-Stevenson WG: Type iv collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 1990;9:289-303.
33. Fishman DA, Bafetti LM, Banionis S, Kearns AS, Chilukuri K, Stack MS: Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells. Cancer 1997;80:1457-1463.
34. Schmalfeldt B, Prechtel D, Halting K, Spathe K, Rutke S, Konik E, Fridman R, Berger U, Schmitt M, Kuhn W Lengyel E: Increased expression of matrix metalloproteinases (mmp)-2, mmp-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 2001;7:2396-2404.
35. Xie W, Feng Q, Su Y, Dong B, Wu J, Meng L, Qu L, Shou C: Transcriptional regulation of pesl expression by c-jun in colon cancer. PLoS One 2012;7:e42253.
36. Wei P, Inamdar N, Vedeckis WV: Transrepression of c-jun gene expression by the glucocorticoid receptor requires bothap-1 sites in the c-jun promoter. Mol Endocrinol 1998;12:1322-1333.
37. Rangatia J, Vangala RK, Treiber N, Zhang P, Radomska H, Tenen DG, Hiddemann W, Behre G: Downregulation of c-jun expression by transcription factor c/ebpalpha is critical for granulocytic lineage commitment. Mol Cell Biol 2002;22:8681-8694.
38. Wei W, Jin J, Schlisio S, Harper JW, Kaelin WG Jr: The v-jun point mutation allows c-jun to escape gsk3-dependent recognition and destruction by the fbw7 ubiquitinligase. Cancer Cell 2005;8:25-33.